Apigenin impedes cell cycle progression at G2 phase in prostate cancer cells

14Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

As a natural flavone, apigenin is abundantly present in vegetables, fruits, oregano, tea, chamomile, wheat sprout and is regarded as a major component of the Mediterranean diet. Apigenin is known to inhibit proliferation in different cancer cell lines by inducing G2/M arrest, but it is unclear whether this action is predominantly imposed on G2 or M phases. In this study, we demonstrate that apigenin arrests prostate cancer cells at G2 phase by flow cytometric analysis of prostate cancer cells co-stained for phospho-Histone H3 and DNA. Concurrently, apigenin also reduces the mRNA and protein levels of the key regulators that govern G2-M transition. Further analysis using chromatin immunoprecipitation (ChIP) confirmed the diminished transcriptional activities of the genes coding for these regulators. Unravelling the inhibitory effect of apigenin on G2-M transition in cancer cells provides the mechanistic understanding of its action and supports the potential for apigenin as an anti-cancer agent. Graphical Abstract: [Figure not available: see fulltext.]

Cite

CITATION STYLE

APA

Hnit, S. S. T., Yao, M., Xie, C., Bi, L., Wong, M., Liu, T., … Dong, Q. (2022). Apigenin impedes cell cycle progression at G2 phase in prostate cancer cells. Discover Oncology, 13(1). https://doi.org/10.1007/s12672-022-00505-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free